Jefferies analyst Akash Tewari was the latest Wall Street analyst to weigh in on the takeover prospects of Horizon Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Mergers and Acquisitions Rumors

Horizon Therapeutics (HZNP) PT Raised to $125 at JefferiesDecember 1, 2022 7:56 AM Increasing unusual option volume: HZNP LBTYA IMAX GOSS EWJ FIS BLMNDecember 1, 2022 3:50 AM 3 Rumors Lighting Up Trading Screens TodayNovember 30, 2022 5:00 PM Midday movers: DoorDash, Workday, Hormel and moreNovember 30, 2022 12:45 PM 'Compelling value' in Viridian Therapeutics following Horizon Therapeutics acquisition talksNovember 30, 2022 10:39 AM Increasing unusual option volume: HZNP SLDP WB BKLN VSCO WOOF IMAX CRWDNovember 30, 2022 10:01 AM Workday, Boeing, Tesla and Airbnb rise premarket; Crowdstrike fallsNovember 30, 2022 8:18 AM Horizon Therapeutics seen worth up to $140/share in takeoverNovember 30, 2022 8:12 AM Horizon Therapeutics (HZNP) option IV into confirms in deal discussionsNovember 30, 2022 5:49 AM After-Hours Movers: Horizon Therapeutics Gains on Takeover Talks, CrowdStrike Sinks on EPSNovember 29, 2022 5:56 PM 3 Rumors Pushing Around Stocks TodayNovember 29, 2022 5:41 PM Horizon Therapeutics (HZNP) jumps after confirming takeover talks with 3 partiesNovember 29, 2022 5:23 PM Form 8-K Horizon Therapeutics For: Nov 29November 29, 2022 5:22 PM Horizon Therapeutics (HZNP) resumes trading, up 39%November 29, 2022 4:55 PM Horizon Therapeutics (HZNP) Confirms Talks on Takeover With Three Large Pharma Cos.November 29, 2022 4:26 PM Horizon Therapeutics plc Confirms Preliminary Discussions Regarding Potential OfferNovember 29, 2022 4:25 PM Horizon Therapeutics (HZNP) Fields Takeover Interest - WSJNovember 29, 2022 4:22 PM